Next Article in Journal
Previous Article in Journal
Mar. Drugs 2013, 11(5), 1677-1692; doi:10.3390/md11051677
Article

c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity

1,* , 1,†
, 1
, 2
, 1
, 1
 and 3
Received: 27 February 2013; in revised form: 1 April 2013 / Accepted: 18 April 2013 / Published: 21 May 2013
View Full-Text   |   Download PDF [780 KB, uploaded 21 May 2013]
Abstract: Plitidepsin is an antitumor drug of marine origin currently in Phase III clinical trials in multiple myeloma. In cultured cells, plitidepsin induces cell cycle arrest or an acute apoptotic process in which sustained activation of c-Jun N-terminal kinase (JNK) plays a crucial role. With a view to optimizing clinical use of plitidepsin, we have therefore evaluated the possibility of using JNK activation as an in vivo biomarker of response. In this study, we show that administration of a single plitidepsin dose to mice xenografted with human cancer cells does indeed lead to increased phosphorylation of JNK in tumors at 4 to 12 h. By contrast, no changes were found in other in vitro plitidepsin targets such as the levels of phosphorylated-ERK, -p38MAPK or the protein p27KIP1. Interestingly, plitidepsin also increased JNK phosphorylation in spleens from xenografted mice showing similar kinetics to those seen in tumors, thereby suggesting that normal tissues might be useful for predicting drug activity. Furthermore, plitidepsin administration to rats at plasma concentrations comparable to those achievable in patients also increased JNK phosphorylation in peripheral mononuclear blood cells. These findings suggest that changes in JNK activity provide a reliable biomarker for plitidepsin activity and this could be useful for designing clinical trials and maximizing the efficacy of plitidepsin.
Keywords: plitidepsin; Aplidin; JNK; biomarker; xenograft plitidepsin; Aplidin; JNK; biomarker; xenograft
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Muñoz-Alonso, M.J.; Álvarez, E.; Guillén-Navarro, M.J.; Pollán, M.; Avilés, P.; Galmarini, C.M.; Muñoz, A. c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity. Mar. Drugs 2013, 11, 1677-1692.

AMA Style

Muñoz-Alonso MJ, Álvarez E, Guillén-Navarro MJ, Pollán M, Avilés P, Galmarini CM, Muñoz A. c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity. Marine Drugs. 2013; 11(5):1677-1692.

Chicago/Turabian Style

Muñoz-Alonso, María J.; Álvarez, Enrique; Guillén-Navarro, María J.; Pollán, Marina; Avilés, Pablo; Galmarini, Carlos M.; Muñoz, Alberto. 2013. "c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity." Mar. Drugs 11, no. 5: 1677-1692.


Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert